Delivery Order SPE2DB20D3505-SPE2DB24FU0F1

Award Date 4/1/24
Potential Completion Date 4/2/24
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,816.55, is for the delivery of Veltassa 8.4 GM powder packets. The contract has a completion date of March 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Veltassa 8.4 GM powder packets. The $12,655.12 firm-fixed-price delivery order contract has an ultimate completion date of July 31, 2024 and is not associated with a set-aside program. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, through which this...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,664.28 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The $1,082.84 delivery order covers the supply of Veltassa 8.4 GM Powder Packets to support military and government healthcare programs. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,664.28 firm-fixed-price contract is for the supply of Veltassa 8.4 GM powder packets, a specialty pharmaceutical product, with a period of performance through April 6, 2023. The contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,624.23, is for the supply of Veltassa 8.4 GM Powder Packets. The contract has a firm fixed price pricing type and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award, valued at $2,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veltassa 8.4 gm powder packets, a specialty medication. The award is a delivery order against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the delivery of Veltassa 8.4 GM powder packets. The contract, valued at $6,134.82, is a delivery order that runs through May 3, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Veltassa 8.4 GM powder packets to the Defense Logistics Agency (DLA). The $1,936.65 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is designated as a Delivery Order with no set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,017.32, is a delivery order for the medication Veltassa 8.4 GM Powder Packet 30S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU0F1
    Delivery Order

This federal contract award, with ID SPE2DB20D3505|SPE2DB24FU0F1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Veltassa 8.4 GM powder packets, a pharmaceutical product, with a total ceiling value of $1,936.65 and a completion date of April 2, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, the company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 2/27/25, 9:43 AM